<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="2-part\PMC6795694\results\search\funders\results.xml">
  <result pre="Translational Research Center, Yonsei UniversitySeoulSouth Korea Edited by: Yanmin Wan," exact="Fudan University," post="China Reviewed by: Peter Palese, Icahn School of Medicine"/>
  <result pre="by: Yanmin Wan, Fudan University, China Reviewed by: Peter Palese," exact="Icahn School of Medicine at Mount Sinai," post="United States; Florian Krammer, Icahn School of Medicine at"/>
  <result pre="Yanmin Wan, Fudan University, China Reviewed by: Peter Palese, Icahn" exact="School of Medicine" post="at Mount Sinai, United States; Florian Krammer, Icahn School"/>
  <result pre="School of Medicine at Mount Sinai, United States; Florian Krammer," exact="Icahn School of Medicine at Mount Sinai," post="United States *Correspondence: Baik Lin Seong blseong@yonsei.ac.kr This article"/>
  <result pre="of Medicine at Mount Sinai, United States; Florian Krammer, Icahn" exact="School of Medicine" post="at Mount Sinai, United States *Correspondence: Baik Lin Seong"/>
  <result pre="Department of Biological Sciences and Biotechnology Major in Bio-Vaccine engineering," exact="Andong National University," post="Andong, South Korea epub: 2019-10-10collection: 20199344received: 2019-5-24accepted: 2019-9-24(C) Jang"/>
  <result pre="HA stalk M2e T cell live attenuated influenza vaccine Funding" exact="National Research Foundation" post="of Korea10.13039/5011000037252018M3A9H40793582018R1D1A1B07048881 Korea Food and Drug Administration10.13039/50110000760319172MFDS255 fig-count: table-count:"/>
  <result pre="UIV is still debated (Krammer et al., 2018b). Recently, the" exact="National Institute of Allergy and Infectious Diseases" post="(NIAID) held a meeting to identify and develop the"/>
  <result pre="(TPP), describing the desired characteristics of a UIV, by the" exact="World Health Organization" post="(WHO) and the Bill and Melinda Gates Foundation (BMGF),"/>
  <result pre="a UIV, by the World Health Organization (WHO) and the" exact="Bill and Melinda Gates Foundation" post="(BMGF), respectively (Table 1). Despite the priority given to"/>
  <result pre="least 5 years 3–5 years At least 1 year NIAID," exact="National Institute of Allergy and Infectious Diseases" post="(https://www.niaid.nih.gov/diseases-conditions/universal-influenza-vaccine-research); BMGF, Bill and Melinda Gates Foundation (https://gcgh.grandchallenges.org/challenges). WHO,"/>
  <result pre="NIAID, National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov/diseases-conditions/universal-influenza-vaccine-research); BMGF," exact="Bill and Melinda Gates Foundation" post="(https://gcgh.grandchallenges.org/challenges). WHO, World Health Organization (https://apps.who.int/iris/bitstream/handle/10665/258767/9789241512466-eng.pdf; https://jsessionid=37D9E056C3EA58A90EE237432AA7D65F?sequence=1). Figure 3"/>
  <result pre="Diseases (https://www.niaid.nih.gov/diseases-conditions/universal-influenza-vaccine-research); BMGF, Bill and Melinda Gates Foundation (https://gcgh.grandchallenges.org/challenges). WHO," exact="World Health Organization" post="(https://apps.who.int/iris/bitstream/handle/10665/258767/9789241512466-eng.pdf; https://jsessionid=37D9E056C3EA58A90EE237432AA7D65F?sequence=1). Figure 3 Protection breadth of influenza vaccines"/>
  <result pre="co-circulate from 1977. After the reemergence of H1N1 in 1977," exact="World Health Organization" post="has issued recommendations for trivalent vaccine composition containing A/H1N1,"/>
  <result pre="of interest. Funding. This work was supported by grants from" exact="National Research Foundation" post="of Korea (NRF-2018R1D1A1B07048881; NRF-2018M3A9H4079358) and also supported by grant"/>
  <result pre="Korea (NRF-2018R1D1A1B07048881; NRF-2018M3A9H4079358) and also supported by grant from the" exact="Ministry of Food and Drug Safety" post="of the Republic of Korea (19172MFDS255). References References AdarY.SingerY.LeviR.TzehovalE.PerkS.Banet-NoachC.et"/>
  <result pre="(2018). A universal influenza vaccine: the strategic plan for the" exact="National Institute of Allergy and Infectious Diseases." post="J. Infect. Dis218, 347–354. 10.1093/infdis/jiy10329506129 ErmlerM. E.KirkpatrickE.SunW.HaiR.AmanatF.ChromikovaV.et al.. (2017)."/>
  <result pre="swine influenza virus haemagglutinin structures: possible origin of influenza subtypes." exact="EMBO" post="J.21, 865–875. 10.1093/emboj/21.5.86511867515 HaiR.KrammerF.TanG. S.PicaN.EgginkD.MaamaryJ.et al.. (2012). Influenza viruses"/>
 </snippets>
</snippetsTree>
